Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Vinblastine and Sirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Including CNS Tumors

NCT01135563 is registered in ClinicalTrials.gov with The Hospital for Sick Children as lead sponsor.

NCT NCT01135563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01135563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Vinblastine and Sirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Including CNS Tumors
Lead sponsor
The Hospital for Sick Children
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2010
Completion date
April 30, 2012
Enrollment
14 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

central nervous system tumors, solid tumors